The project will be instrumental in enhancing the company's API manufacturing capacity and global reach
Globally, BRUKINSA is approved in more than 70 countries
The approval is for the generic version of Victoza, indicated for the treatment of insufficiently controlled Type 2 Diabetes Mellitus
Newly commissioned MCC in Jhagadia and Dahej and CCS project expansions will unlock an additional 8,800 MTPA, fuelling year-over-year revenue gains of 20%-30% in excipients
The initiative was announced at World Hypertension Congress, Chennai
The company reported sustained increase in formulations' share despite slowdown in productivity of Gagillapur facility
During the quarter, US formulations revenue increased by 13.5 per cent YoY to Rs. 4,072 crore
Allopurinol is used to prevent or lower high uric acid levels in the blood
The company has posted net profit of Rs. 1,986.43 crores for the Financial Year ended March 31, 2025
IICP is a registered charitable society working in the disability sector since 1974
Subscribe To Our Newsletter & Stay Updated
